Leerink Partners raises Veradermics target price to $150 from $135
MANE•Leerink Partners raised its target price for Veradermics to $150 from $135.
Related News
The Metals Company expects final US permit decision by mid-December
TMC•
Morgan Stanley cuts total voting rights in Norma Group to 5.18% from 5.65%
MS•
US tech stocks rise after last week's selloff; Nvidia falls
QQQ•
Sun Life publishes Q3 2026 earnings call transcript
SLF•
Syndax Pharmaceuticals reports 90% growth in Revuforj quarterly net revenue to $60.7 million
SNDX•